 |
 |
|
 |
 |
 |
 |
 |
 |
|
|
Exenatide Nasal
This novel formulation of exenatide for diabetes patients is in the early investigative phase and continues to show potential. |
|
SYMLIN ®
|
Home |
About Us |
Pipeline |
Research |
Investors |
Careers |
Site Map |
Terms of Use |
Updates |
PRIVACY © 2006 Amylin Pharmaceuticals, Inc. - All Rights Reserved |